These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 1707908)
21. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells. Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624 [TBL] [Abstract][Full Text] [Related]
22. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells. Seo N; Tokura Y; Takigawa M; Egawa K J Immunol; 1999 Jul; 163(1):242-9. PubMed ID: 10384122 [TBL] [Abstract][Full Text] [Related]
23. Expression and function of CD7 molecule on human natural killer cells. Rabinowich H; Pricop L; Herberman RB; Whiteside TL J Immunol; 1994 Jan; 152(2):517-26. PubMed ID: 7506726 [TBL] [Abstract][Full Text] [Related]
24. Target cell lysis and IL-2 secretion by gamma/delta T lymphocytes after activation with bacteria. Munk ME; Gatrill AJ; Kaufmann SH J Immunol; 1990 Oct; 145(8):2434-9. PubMed ID: 2145360 [TBL] [Abstract][Full Text] [Related]
25. Porcine T lymphocytes and NK cells--an update. Gerner W; Käser T; Saalmüller A Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948 [TBL] [Abstract][Full Text] [Related]
26. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing. Wiebke EA; Custer MC; Rosenberg SA; Lotze MT J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373 [TBL] [Abstract][Full Text] [Related]
27. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression. Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970 [TBL] [Abstract][Full Text] [Related]
28. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways. Karlhofer FM; Yokoyama WM J Immunol; 1991 May; 146(10):3662-73. PubMed ID: 2026886 [TBL] [Abstract][Full Text] [Related]
29. Selective lysis of the autologous tumor by delta TCS1+ gamma/delta+ tumor-infiltrating lymphocytes from human lung carcinomas. Zocchi MR; Ferrarini M; Rugarli C Eur J Immunol; 1990 Dec; 20(12):2685-9. PubMed ID: 1702723 [TBL] [Abstract][Full Text] [Related]
30. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells. Burns GF; Triglia T; Werkmeister JA J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374 [TBL] [Abstract][Full Text] [Related]
31. Induction of lysis by T cell receptor gamma delta+/CD3+ T lymphocytes via CD2 requires triggering via the T11.1 epitope only. Goedegebuure PS; Segal DM; Braakman E; Vreugdenhil RJ; Van Krimpen BA; Van de Griend RJ; Bolhuis RL J Immunol; 1989 Mar; 142(6):1797-802. PubMed ID: 2466076 [TBL] [Abstract][Full Text] [Related]
32. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition. Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809 [TBL] [Abstract][Full Text] [Related]
33. PGE2 inhibits natural killer and gamma delta T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling. Martinet L; Jean C; Dietrich G; Fournié JJ; Poupot R Biochem Pharmacol; 2010 Sep; 80(6):838-45. PubMed ID: 20470757 [TBL] [Abstract][Full Text] [Related]
34. Human CD3 gamma delta + activated lymphocytes exhibit killer activity in vitro against autologous leukemic cells. Bensussan A; Lagabrielle JF; Castaigne S; Boisson N; Miclea JM; Benbunan M; Degos L Nouv Rev Fr Hematol (1978); 1989; 31(2):129-32. PubMed ID: 2528119 [TBL] [Abstract][Full Text] [Related]
35. Human V gamma 9-V delta 2 T cell receptor-gamma delta lymphocytes show specificity to Daudi Burkitt's lymphoma cells. Sturm E; Braakman E; Fisch P; Vreugdenhil RJ; Sondel P; Bolhuis RL J Immunol; 1990 Nov; 145(10):3202-8. PubMed ID: 2146317 [TBL] [Abstract][Full Text] [Related]
36. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes. Voogt PJ; Falkenburg JH; Fibbe WE; Veenhof WF; Hamilton M; Van Krimpen BA; Bolhuis RL J Immunol; 1989 Mar; 142(5):1774-80. PubMed ID: 2521886 [TBL] [Abstract][Full Text] [Related]
37. Characterization and function of the NKR-P1dim/T cell receptor-alpha beta+ subset of rat T cells. Brissette-Storkus C; Kaufman CL; Pasewicz L; Worsey HM; Lakomy R; Ildstad ST; Chambers WH J Immunol; 1994 Jan; 152(2):388-96. PubMed ID: 7506720 [TBL] [Abstract][Full Text] [Related]
38. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose. Zollner TM; Zhu HG; Anderer FA Anticancer Res; 1993; 13(4):923-30. PubMed ID: 8352560 [TBL] [Abstract][Full Text] [Related]
39. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation. Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650 [TBL] [Abstract][Full Text] [Related]
40. Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex. Lanier LL; Le AM; Cwirla S; Federspiel N; Phillips JH Fed Proc; 1986 Nov; 45(12):2823-8. PubMed ID: 3095151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]